Shukra Pharma.

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "33.09",
    "chg": 3,
    "chgp": "9.97%",
    "dir": 1,
    "prev_price": "30.09",
    "mcapval": "1,383.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "Aug 05, 03:30 PM",
    "curr_time": "08:29 AM",
    "last_traded_at": "Aug 05, 03:30 PM IST",
    "bse_nse_vol": "9.51 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 05, 2026",
    "traded_date_str": "2026 08 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Shukra Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shukra-pharmaceuticals-ltd-4130801",
        "imagepath": "",
        "date": "2026-07-31 23:17:07",
        "description": "The next results date for Shukra Pharmaceuticals Ltd is scheduled for August 11, 2026...."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4130093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_mojoScore_4130093.png",
        "date": "2026-07-31 10:11:06",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4109033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_mojoScore_4109033.png",
        "date": "2026-07-20 10:10:41",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-faces-mixed-technical-signals-amid-price-momentum-shift-4099876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4099876.png",
        "date": "2026-07-14 08:02:25",
        "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bearish. Despite some bullish signals on weekly indicators, monthly trends and moving averages suggest caution for investors as the stock price declined by 1.63% on 14 Jul 2026, closing at ₹33.89."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4094930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_mojoScore_4094930.png",
        "date": "2026-07-09 10:11:23",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4092788",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4092788.png",
        "date": "2026-07-08 08:02:38",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways movement. Despite a strong intraday gain of 4.78%, the stock’s technical landscape remains nuanced, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4089924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4089924.png",
        "date": "2026-07-06 08:01:41",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 7.57% gain on 6 July 2026, signalling a potential change in market sentiment. Despite this short-term strength, technical indicators present a nuanced picture, with several metrics suggesting a cautiously bearish outlook amid mixed signals from key oscillators and moving averages."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4075951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_mojoScore_4075951.png",
        "date": "2026-06-28 10:10:06",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4058921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_mojoScore_4058921.png",
        "date": "2026-06-17 10:10:03",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 651,
    "sid": "505931",
    "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Quarterly Results",
      "datetime": "30-Jul-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June 2026 along with the Auditors Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday July 14 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR)",
      "datetime": "14-Jul-2026",
      "details": "The Board took on record and confirmed that in accordance with the terms of the aforesaid Special Resolution and the applicable provisions of Chapter V of the SEBI ICDR Regulations the allottees were required to bring in the differential upfront amount of Rs. 0.39 per Warrant (aggregating to Rs. 1810770/-) being the additional amount payable on the upfront 25% (Twenty-Five Per Cent) consideration on account of the re-computation of the issue price from Rs. 34.00 to Rs. 35.56 per Warrant within fifteen (15) days from the date of passing of the Special Resolution. Further Two Allottees have also paid the balance 75% (Seventy-Five Per Cent) of the Warrant Issue Price of differential consideration on or before July 13 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "06-Jul-2026",
      "details": "EGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Shukra Pharmaceuticals Ltd?

2026-07-31 23:17:07

The next results date for Shukra Pharmaceuticals Ltd is scheduled for August 11, 2026....

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-07-31 10:11:06

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-07-20 10:10:41

Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift

2026-07-14 08:02:25

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bearish. Despite some bullish signals on weekly indicators, monthly trends and moving averages suggest caution for investors as the stock price declined by 1.63% on 14 Jul 2026, closing at ₹33.89.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-07-09 10:11:23

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-08 08:02:38

Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways movement. Despite a strong intraday gain of 4.78%, the stock’s technical landscape remains nuanced, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages.

Read full news article

Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-07-06 08:01:41

Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 7.57% gain on 6 July 2026, signalling a potential change in market sentiment. Despite this short-term strength, technical indicators present a nuanced picture, with several metrics suggesting a cautiously bearish outlook amid mixed signals from key oscillators and moving averages.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-06-28 10:10:06

Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-06-17 10:10:03

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News